- Compare UK Investments
- Where To Invest
- Trade Shares
- Trade FTSE100 Shares
- Trade FTSE250 Shares
- Trade AIM Shares
- Trade European Shares
- Trade DJ30 Shares
- Trade S&P500 Shares
- Trade Forex
- Trade Commodities
- Trade Energy Commodities
- Trade Metal Commodities
- Trade Soft Commodities
- Recommended Financial Spread Betting Books
Trade GlaxoSmithKline Shares
|
|||||||||||||||||||||||||||||||||||||
GlaxoSmithKline and Market Latest NewsYahoo! Finance: GSK.L NewsColgate 'nurdles' Glaxo over toothpaste stripes (Other) To consumers, it is the three-striped wave of toothpaste that sits atop their toothbrush every morning. But to Colgate-Palmolive the "nurdle" as the stripey slug of toothpaste is known in technical terms is worth going to court over.
UPDATE 4-Colgate sales weak, shares off 7 pct (Other)Industry veterans join Proximagen (ShareCast) Proximagen, the biotechnology company focused on diseases of the central nervous system, said 2010 is shaping up to be another very good year for the company.
NEWSMAKER-Sanofi's new broom CEO gets serious on M&A (Other)AstraZeneca doubles buyback as Brilinta shines (Reuters MOLT) WRAPUP 1-Sanofi seeks Genzyme fix, Astra gets new drug lift (Other) FTSE rises as investors cheer corporate results (Reuters MOLT) INVESTOR PROFILE-Manek prescribes India for double-dip fears (Other) FTSE rises as investors cheer UK corporate results (Other) UPDATE 2-AstraZeneca doubles buyback as Brilinta shines (Other) UPDATE 4-Sanofi to make formal Genzyme offer - sources (Other) UPDATE 3-Sanofi to press ahead on Genzyme bid-source (Other) Energy weakness knocks FTSE; banks, miners firm (Reuters MOLT) Energy weakness knocks FTSE; banks, miners firm (Other) Banks and miners help FTSE higher (Reuters MOLT) Banks, miners help Britain's FTSE higher (Other) FTSE seen opening flat (Reuters MOLT) 7 More Years Until We're Out Of The Woods Rational pessimist Bill Bonner says the market will be flat, but that doesn't mean you can't generate good income from these high yielding stars.
UPDATE 1-UK govt finds extra 50 mln pounds for cancer drugs (Other)Wednesday preview: Centrica, BATs, Compass (ShareCast) It's another busy day for results on Wednesday with Footsie stalwarts BG Group, BATs, Compass, Invensys, Rexam, Rolls-Royce, Sage and Centrica all fighting for attention.
Copyright (c) 2010 Yahoo! Inc. All rights reserved.
|
|||||||||||||||||||||||||||||||||||||
GlaxoSmithKline: Financial Spread Betting vs CFD vs Share DealingTable below compares Financial Spread Betting, Contract For Difference and Share Dealing trading. For simplicity we use the average brokerage fees to calculate the profit/loss if £1,000 available for investment in GlaxoSmithKline shares (GlaxoSmithKline share price is 2300p). Supposedly, you think that GlaxoSmithKline shares will go up by 10% in one month.
|
|||||||||||||||||||||||||||||||||||||
GlaxoSmithKline: Financial Spread Betting and Contracts For Difference (CFDs) are margined (or leveraged) products and let you go long (buy) or short (sell) with GlaxoSmithKline shares, they are more suitable for short and medium term investments and cover a wide range of markets, including shares, indices, commodities and currencies. Share investing, on the other hand, is a conservative and old way of gaining financial independence and preserving capital. Even though some stockbrokers offer credit facilities it is very rare and not popular amongst private investors.
Risk Warning: Financial Spread Betting and Contracts For Difference (CFDs) are leveraged products and carry a high level of risk to your capital. You may lose more than your initial investment. Share price can go down as well as up and returns on investments are not guaranteed.